Rotational Rheometer System

The FDA Center for Drug Evaluation and Research (CDER) is procuring a Rotational Rheometer System under solicitation 75F40126Q133238. The agency requires a system that meets specific Minimum Technical Requirements (MTRs) for performance and measurement, with delivery to Silver Spring, Maryland. Evaluation follows a Lowest Price Technically Acceptable (LPTA) methodology. Quotes are due June 12, 2026, at 2:00 PM EDT. Submissions must adhere to electronic formatting rules, including a prohibition on macros. Required documentation includes an Accessibility Conformance Report (ACR) and Buy American Act representations. The solicitation package details the Statement of Need, schedule of items, and applicable FAR and HHSAR clauses. The FDA Center for Drug Evaluation and Research (CDER) is procuring a Rotational Rheometer System under solicitation 75F40126Q133238. The requirement falls under NAICS code 334516 for Analytical Instrument Manufacturing. The agency seeks a complete system for its Silver Spring, Maryland facilities. The FDA Center for Drug Evaluation and Research (CDER) requires a turn-key Rotational Rheometer System to replace end-of-life laboratory equipment. This system supports the Office of Pharmaceutical Quality (OPQ) in bioprocessing research, specifically for therapeutic protein production. The unit must be a new, latest-model system, not a demonstration or refurbished model.